| Literature DB >> 21788931 |
Marijana Zovko Končić1, Monika Barbarić, Ivana Perković, Branka Zorc.
Abstract
Reactive oxygen species, along with reactive nitrogen species, may play an important role in the pathogenesis and progress of many diseases, including cancer, diabetes and sickle cell disease. It has been postulated that hydroxyurea, one of the main treatments in sickle cell disease, achieves its activity partly also through its antioxidant properties. A series of hydroxyurea derivatives of L- and D-amino acid amides and cycloalkyl-N-aryl-hydroxamic acids was synthesized and investigated for their radical scavenging activity, chelating properties and antioxidant activity. All the compounds showed exceptional antiradical activities. For example, free radical scavenging activities of investigated hydroxyureas were higher than the activity of standard antioxidant, butylated hydroxyanisole (BHA). Moreover, most of the investigated hydroxamic acids were stronger Fe²⁺ ion chelators than quercetin. In addition, the investigated compounds, especially hydroxamic acids, were proven to be excellent antioxidants. They were as effective as BHA in inhibiting β-carotene-linoleic acid coupled oxidation. It is reasonable to assume that the antioxidant activity of the investigated compounds could contribute to their previously proven biological properties as cytostatic and antiviral agents.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21788931 PMCID: PMC6264354 DOI: 10.3390/molecules16086232
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Hydroxyureas 1–5 and hydroxamic acids 6–11 investigated in this study.
Figure 2Radical scavenging activities of hydroxyureas 1–5 and hydroxamic acids 6–11 expressed as EC50 (means ± SD, n = 3). Statistically significant differences: * less active than BHA; † more active than BHA (P < 0.05).
Log P and reactivity in β-carotene-linoleate assay.
| Compound | Log | ||
|---|---|---|---|
|
| 3.12 | 62.45 ± 5.55 * | 63.46 ± 3.01 * |
|
| 2.30 | 64.47 ± 5.55 * | 65.72 ± 3.06 * |
|
| 3.23 | 60.67 ± 5.43 * | 63.15 ± 3.37 * |
|
| 2.46 | 60.66 ± 1.38 * | 62.80 ± 0.89 * |
|
| 3.41 | 67.33 ± 4.71 * | 69.93 ± 2.84 * |
|
| 2.02 | 72.73 ± 2.45 * | 73.76 ± 1.14 |
|
| 3.79 | 89.13 ± 1.89 † | 88.55 ± 0.92 |
|
| 3.34 | 88.61 ± 1.74 † | 88.03 ± 1.15 |
|
| 3.82 | 94.39 ± 1.03 † | 94.22 ± 1.19 |
|
| 4.25 | 89.86 ± 0.97 † | 89.54 ± 1.80 † |
|
| 1.53 | 54.96 ± 4.67 * | 57.43 ± 2.53 * |
| BHA |
| 79.59 ± 2.06 | 80.55 ± 1.43 |
a means ± SD (n = 3); b antioxidant activity; c normalized antioxidant activity at 60-min of incubation; n.c.: not calculated; Statistically significant differences within columns: * less active than BHA; † more active than BHA (P < 0.05).
Figure 3Fe2+ chelating activities of hydroxyureas 1–5 and hydroxamic acids 6–11 expressed as EC50 (means ± SD, n = 3). Statistically significant differences: * less active than EDTA; † less active than quercetin; ‡ more active than quercetin (P < 0.05).
Figure 4Bleaching of emulsion with β-carotene in presence of hydroxyureas 1–5 and hydroxamic acids 6–11 (means ± SD, n = 3). Absorbance was measured at λ = 470 nm.